Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04514159
Title A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Zeno Alpha Inc.

Her2-receptor negative breast cancer


Abemaciclib + ZN-c5

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.